Dr. Kalinsky on Optical Imaging for HER2+ Breast Cancer

Kevin Kalinsky, MD
Published: Tuesday, Feb 21, 2017



Kevin Kalinsky, MD, assistant professor of Medicine at Columbia University Medical Center, discusses the potential advantages of optical imaging for patients with HER2-positive breast cancer.

Some patients with breast cancer are unable to tolerate MRIs, which makes non-invasive optical imaging beneficial, explains Kalinsky. There is no intravenous injection needed, allowing it to be relatively quick and inexpensive.



Kevin Kalinsky, MD, assistant professor of Medicine at Columbia University Medical Center, discusses the potential advantages of optical imaging for patients with HER2-positive breast cancer.

Some patients with breast cancer are unable to tolerate MRIs, which makes non-invasive optical imaging beneficial, explains Kalinsky. There is no intravenous injection needed, allowing it to be relatively quick and inexpensive.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x